Clinical Trials Logo

Cancer Prostate clinical trials

View clinical trials related to Cancer Prostate.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04836221 Completed - Hypertension Clinical Trials

Comorbidities And Reducing inEquitieS

CARES
Start date: May 5, 2021
Phase: N/A
Study type: Interventional

Black cancer patients tend to have worse outcomes than White cancer patients. Some of this disparity may be due to comorbidities. The purpose of this study is to improve management of co-morbidities among cancer patients in order to improve cancer outcomes and improve health equity. Comorbidities such as diabetes and hypertension can complicate cancer treatment or can make it difficult to reach optimal health after treatment. This study will offer additional support and tools to manage cancer patient's health needs. First, the study will use a mobile health application, managed by a company called Welldoc, to monitor patient progress in real time and to provide ongoing guidance. Second, the study will connect patients with a Community Health Worker who will speak with them weekly to discuss self-care information, including medical scheduling or appointment needs, and assist with daily self-monitoring of blood pressure and/or blood glucose monitoring. Lastly, an oncology nurse will monitor reported health and triage any medical needs and whether additional medical care is needed.

NCT ID: NCT04074460 Completed - Cancer, Breast Clinical Trials

Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study

VAPOR-C
Start date: August 27, 2017
Phase: Phase 4
Study type: Interventional

A multicentre, prospective randomized, active-controlled feasibility trial of volatile-based anaesthesia vs. propofol-based total intravenous anaesthesia to investigate the impact of anaesthesia on long-term (i.e. 5-years) patient cancer outcomes in patients undergoing elective major cancer surgery.

NCT ID: NCT03866785 Completed - Cancer Prostate Clinical Trials

Physical Activity Experiment on Male Prostate Cancer Patients

ACTI_PAIR
Start date: August 2, 2018
Phase: N/A
Study type: Interventional

Prostate cancer is the most common cancer in France (56,841 cases in 2012). Although the benefits of physical activity (PA) in cancer patients are currently well established in the scientific literature, several studies have shown that this population is not sufficiently active. Strengthen patient adherence to prevention counseling by the physical activity (PA) is emerging as a new challenge for personalized treatment in oncology. In order to encourage the engagement and maintenance in a regular PA of cancer patients, first, their experiences of physical activity (PA) practice should be considered and their initial social representations of the practice considered. Secondarily, it is also important to identify health professionals who retain a key role in defining the framework, objectives and means of action to promote lifestyle changes towards a more active lifestyle. In addition, peer mentoring appears to offer promising perspectives for promoting adherence and long-term maintenance in physical activity (PA) of cancer patients.

NCT ID: NCT00172055 Completed - Cancer Prostate Clinical Trials

Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy

Start date: December 2004
Phase: Phase 3
Study type: Interventional

The objective of the study is to investigate whether blood markers can be used to predict the development of bone metastases and to assess the efficacy and safety of zoledronic acid in cancer treatment induced bone loss.